ThinkSabio

$OKYO

$1.50▲ +2.0% YTD

2 SEC 13D/G filings tracked · Last updated Oct 6, 2026

Filing History
News
OKYO ▲ +2.0% - OKYO Pharma Limited
CP $1.50▲ +2.0%Oct 6, 2026 · ThinkSabio Blog

$OKYO - OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain…

News
OKYO ▼ -1.9% - OKYO Pharma Limited
CP $1.54▲ -1.9%Sep 8, 2026 · ThinkSabio Blog

$OKYO - OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference…